Skip to main content
Advertisement

AI Bias Analysis

4 models · Takes ~15 seconds

CNBC

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

EconomyDaily Composite
ShareXFacebook

Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake.

C

Source

CNBC

Read full article at CNBC

Opens original article in a new tab

Advertisement

Related Economy Stories

Advertisement